✦ LIBER ✦

Effect of age on the pharmacokinetics of oral levodopa in patients with Parkinson's disease

✍ Scribed by M. Contin; R. Riva; P. Martinelli; F. Albani; A. Baruzzi

Publisher: Springer
Year: 1991
Tongue: English
Weight: 436 KB
Volume: 41
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00626370

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and effects of levodopa

Pharmacokinetics and effects of levodopa in advanced Parkinson's disease

✍ E. Bredberg; J. Tedroff; S.-M. Aquilonius; L. Paalzow 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 557 KB

Five patients with severe Parkinson's disease were characterized with respect to their pharmacokinetic and pharmacodynamic responses to levodopa given: orally, intravenously (three different infusion rates) and intraduodenally. The best therapeutic infusion rate in the intravenous study was used for

Effect of duration of levodopa/decarboxy

Effect of duration of levodopa/decarboxylase inhibitor therapy on the pharmacokinetic handling of levodopa in elderly patients with idiopathic Parkinson's disease

✍ S. G. Bowes; C. J. A. O'Neill; P. W. Nicholson; A. L. Leeman; A. A. Deshmukh; R. 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 450 KB

Effect of entacapone, a COMT inhibitor,

Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease

✍ V. V. Myllylä; K. A. Sotaniemi; A. Illi; K. Suominen; T. Keränen 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 563 KB

In an open, randomised, cross-over study we investigated the effect of a single 200 mg oral dose of entacapone, a novel catechol-O-methyltransferase (COMT) inhibitor, on the pharmacokinetics and metabolism of levodopa/carbidopa, and on the cardiovascular responses (blood pressure and pulse rate vari

Clinical and pharmacokinetic comparison

Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson's disease with a fluctuating response to levodopa

✍ D. Deleu; G. Ebinger; Y. Michotte 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 634 KB

Effects of tolcapone, a catechol-O-methy

Effects of tolcapone, a catechol-O-methyltransferase inhibitor, on motor symptoms and pharmacokinetics of levodopa in patients with Parkinson's disease

✍ M. Yamamoto; M. Yokochi; S. Kuno; Y. Hattori; Y. Tsukamoto; H. Narabayashi; H. T 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 517 KB

Exercise improves efficacy of levodopa i

Exercise improves efficacy of levodopa in patients with Parkinson's disease

✍ Siegfried Muhlack; Jacub Welnic; Dirk Woitalla; Thomas Müller 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

## Abstract The objective was to investigate the impact of exercise on absorption and efficacy of levodopa (LD) in patients with Parkinson‘s disease (PD). A soluble, immediate release LD formulation was given followed by exercise near the aerobic limit on one day to PD patients, who underwent the s